Cara Therapeutics | Spese Operative

Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Cassava Sciences USD 27.88M 898K 2023-09
Cipla INR 52.34B 1.6B 2023-09
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 10.63M 414K 2023-09
CSL USD 5.19B 142.6M 2023-06
Grifols EUR 1.35B 73.17M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pacira USD 148.08M 1.87M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
RedHill Biopharma USD 6.2M 31.68M 2023-06
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12



Cara Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.